Effects of a selective cannabinoid CB2 agonist and antagonist on intravenous nicotine self administration and reinstatement of nicotine seeking
about
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilitiesRole of cues and contexts on drug-seeking behaviourExpression of functional cannabinoid CB2 receptor in VTA dopamine neurons in ratsMonoacylglycerol lipase (MAGL) inhibition attenuates acute lung injury in miceDistinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?Endocannabinoid signalling in reward and addiction.Role of CB2 cannabinoid receptors in the rewarding, reinforcing, and physical effects of nicotineAttenuation of Cocaine-Induced Conditioned Place Preference and Motor Activity via Cannabinoid CB2 Receptor Agonism and CB1 Receptor Antagonism in Rats.The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in miceSpecies differences in cannabinoid receptor 2 and receptor responses to cocaine self-administration in mice and ratsRole of the endogenous cannabinoid system in nicotine addiction: novel insights.AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacologyCB2R orchestrates fibrogenesis through regulation of inflammatory response during the repair of skeletal muscle contusion.Therapeutic modulation of cannabinoid lipid signaling: metabolic profiling of a novel antinociceptive cannabinoid-2 receptor agonistEffects of various cannabinoid ligands on choice behaviour in a rat model of gambling.Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors.Peroxisome proliferator-activated receptor (PPAR) agonists as promising new medications for drug addiction: preclinical evidence.Transient Cannabinoid Receptor 2 Blockade during Immunization Heightens Intensity and Breadth of Antigen-specific Antibody Responses in Young and Aged mice.Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives.Cannabinoid CB2 Receptor Mediates Nicotine-Induced Anti-Inflammation in N9 Microglial Cells Exposed to β Amyloid via Protein Kinase C.Interactions between nicotine and drugs of abuse: a review of preclinical findings.Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites.Extinction bursts in rats trained to self-administer nicotine or food in 1-h daily sessions.Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats.Getting to the core of addiction: Hooking CB2 receptor into drug abuse?Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
P2860
Q24623282-7689C43D-6452-43D5-8D66-CE7A13F99226Q26825476-F1CE2ED9-61AB-4FF8-B771-EDC2BD658CC3Q28272826-092E8217-254E-42D4-8D7F-860938D07C7FQ28534648-3A618E34-4382-485A-9A5D-98DF5628C50DQ28540537-D95FB35D-8907-4C42-886C-885979EBBBEDQ30373359-17C46B0A-5816-4091-953D-14E1683F4281Q30551483-AA1D51AF-A498-4EF1-97F9-647737B00CA5Q33614204-2B17CA25-EA49-4E6D-A288-E7025C733B50Q33703839-1EA50EA0-1900-4A96-8A98-1615A3ACE390Q35089428-F5494ADC-58FF-4600-B766-0C260182A4F8Q35216481-CE74F0C3-A547-4701-9561-4467DC9B2900Q35223957-EEC45CBB-A933-4213-864F-216370C55C15Q35740902-49ED1A48-4C56-4FF2-8DC2-AC6651E2D894Q36385052-0C6FED3B-F035-48A5-883E-B872447518C1Q36715987-7D892BD3-8736-4F35-900A-86A33C48DDB0Q36938493-95086FD0-BA52-49F0-BB3E-170589BFF630Q37304747-A98AFC3B-6E6A-4192-8D89-4FE8CDBDAF01Q37648708-08AEA911-B15A-4A85-A2E9-40976F0C4669Q38686274-ECB48275-B58A-47B6-97C5-74A4BDDFABE9Q38793610-73291283-7532-402C-9E24-D40080389DC0Q38824915-4BE6F0A3-39F0-49C7-8E0D-5488C51E7171Q39052265-869EF8AA-4379-4BC2-AAC8-EF6253BDF04EQ41349799-009013C3-082E-4D69-BF1F-99D6FA35ACEDQ44738063-4B3266C6-97DA-4C94-8CA1-BE98FF8A1EDFQ48581200-92461521-D858-46EF-AB1D-09CEA6E9D000Q50534434-0EA3BD0A-FA7C-4BFF-AD9C-D3AAD6E65ADC
P2860
Effects of a selective cannabinoid CB2 agonist and antagonist on intravenous nicotine self administration and reinstatement of nicotine seeking
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Effects of a selective cannabi ...... nstatement of nicotine seeking
@ast
Effects of a selective cannabi ...... nstatement of nicotine seeking
@en
Effects of a selective cannabi ...... nstatement of nicotine seeking
@nl
type
label
Effects of a selective cannabi ...... nstatement of nicotine seeking
@ast
Effects of a selective cannabi ...... nstatement of nicotine seeking
@en
Effects of a selective cannabi ...... nstatement of nicotine seeking
@nl
prefLabel
Effects of a selective cannabi ...... nstatement of nicotine seeking
@ast
Effects of a selective cannabi ...... nstatement of nicotine seeking
@en
Effects of a selective cannabi ...... nstatement of nicotine seeking
@nl
P2093
P2860
P1433
P1476
Effects of a selective cannabi ...... nstatement of nicotine seeking
@en
P2093
Alexander Zvonok
Islam Gamaleddin
Steven R Goldberg
P2860
P304
P356
10.1371/JOURNAL.PONE.0029900
P407
P577
2012-01-01T00:00:00Z